SUMMARY Acquired dysfibrinogenaemia as the cause of coagulation abnormalities occurred in a case of acute pancreatitis. Initial coagulation studies showed a prolonged thrombin time and increased concentrations of serum fibrinogen/fibrin degradation products and plasma D-dimer. Further studies on purified fibrinogen showed evidence of degradation of the C-terminal ends of the A-alpha chains, which, it is suggested, resulted from the action of circulating pancreatic proteases. Fibrin polymerisation was thus shown to be impaired, which explains the prolongation of the thrombin time. There was a temporal relation between increased amylase activities and the prolonged thrombin time, both of which returned to normal three weeks after admission. Acquired dysfibrinogenaemia may be an underrecognised phenomenon in acute pancreatitis and may lead to misinterpretation of coagulation test abnormalities.
Disseminated intravascular coagulation (DIC) with accompanying activation of the fibrinolytic system is a recognised complication of acute pancreatitis. ' We report the association of acute pancreatitis with a coagulation abnormality caused in part by probable mild DIC but predominantly by a previously undescribed acquired abnormality of figrinogen. Failure to recognise this acquired dysfibrinogenaemia may lead to a misinterpretation of coagulation test data.
Case report A 45 year old woman presented with a two month history of epigastric pain radiating through to her back. She had lost 2 stone in weight over the previous six months but admitted to dieting. Examination showed that she was thin and anxious, with a tender epigastric mass. There was no hepatosplenomegaly or lymphadenopathy.
Her haemoglobin concentration was 8 2 g/dl (red cell changes consistent with iron deficiency); white cells were 9-7 x 109/l, normal differential; platelet count was 558 x 109/1; erythrocyte sedimentation rate was 61 mm/first hour; urea, electrolytes, and liver It has been suggested that DIC can be precipitated in pancreatitis through the action of circulating pancreatic proteases, especially trypsin, on the coagula-617 tion factors, so triggering the clotting cascade.' The finding ofa raised D-dimer concentration (a marker of circulating products from the degradation of crosslinked fibrin) and the slight reduction in the ratio of fibrinopeptide A to B release from the fibrinogen in plasma (suggesting the presence of fibrin monomer) indicates that DIC was probably present. The persistently normal platelet count and prothrombin time would suggest that the DIC was only mild.
There were two main observations which indicated that DIC may not have been the sole cause of the coagulation abnormalities, prompting investigation for the presence of a dysfibrinogenaemia. Firstly, although a prolonged thrombin time can occur in DIC as a consequence of hypofibrinogenaemia or inhibition of the thrombin-fibrinogen interaction by circulating fibrinogen degradation products,8 it would be unusual for this to occur in the absence of abnormalities of other clotting tests. Secondly, a close relation exists between serum fibrinogen degradation product and D-dimer concentrations in DIC.9 In this case the serum fibrinogen degradation product value was disproportionately higher than would have been expected for the observed D-dimer concentration. Although degradation products resulting from the DIC would have contributed towards the increased value of fibrinogen degradation product level, it was thought possible that the very high value obtained was, in part, a spurious finding due to the detection of functionally abnormal fibrin which had remained in the serum following the in vitro preparation of the test sample.
Further studies showed a loss of peptides from the C-terminus end of the A-alpha chains of the fibrinogen. We suggest that this occurred as a consequence of the action of circulating pancreatic proteases either directly on the fibrinogen or indirectly via activation of plasminogen to plasmin. This proteolytic cleavage was presumably the cause ofthe reduced polymerisation of purified fibrin observed in vitro and explains the prolonged thrombin time. The close temporal relation between the increased amylase activities and the prolonged thrombin time which persisted for three weeks following admission would support a case for implicating pancreatic proteases as the cause of the dysfibrinogenaemia. It would be unlikely for the degree of fibrinogenolysis observed to have been a consequence offibrinolytic activation secondary to the coexisting DIC.
As far as we are aware, an acquired abnormality of fibrinogen of the severity described here occurring in association with acute pancreatitis has not previously been reported. The only reported cases of acquired dysfibrinogenaemia have occurred in association with liver disorders.' '2 The defect in these cases seems to be due to an abnormality in fibrin monomer polymerisa-618 Wilde, Thomas, Lane, Greaves, Preston tion. It has been suggested that this arises because of the development of abnormalities of the carbohydrate moieties in the fibrinogen molecule as a result of liver dysfunction'3 but increased proteolytic degradation of fibrinogen may also be a factor.'4 Acquired dysfibrinogenaemia may be an under-recognised phenomenon in acute pancreatitis and could lead to misinterpretation of coagulation test abnormalities resulting in the administration of inappropriate treatment.
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